Yang N, He Z, Lang T
Pharmaceutics. 2025; 17(2).
PMID: 40006592
PMC: 11859595.
DOI: 10.3390/pharmaceutics17020225.
Xu Y, Reheman A, Feng W
Front Bioeng Biotechnol. 2025; 13:1550089.
PMID: 39991139
PMC: 11842396.
DOI: 10.3389/fbioe.2025.1550089.
Chen L, Yang J, Jia L, Wei X, Wang H, Liu Z
J Nanobiotechnology. 2025; 23(1):19.
PMID: 39819479
PMC: 11740360.
DOI: 10.1186/s12951-024-03084-1.
Yang K, Wu Z, Zhang K, Weir M, Xu H, Cheng L
Front Pharmacol. 2024; 15:1437457.
PMID: 39144636
PMC: 11322102.
DOI: 10.3389/fphar.2024.1437457.
Jiang Z, Li J, Wang J, Pan Y, Liang S, Hu Y
J Nanobiotechnology. 2024; 22(1):152.
PMID: 38575979
PMC: 10996189.
DOI: 10.1186/s12951-024-02398-4.
Synergistic glycolysis disturbance for cancer therapy by a MOF-based nanospoiler.
Zeng X, Ruan Y, Wang L, Deng J, Yan S
Biophys Rep. 2023; 9(3):134-145.
PMID: 38028149
PMC: 10648233.
DOI: 10.52601/bpr.2023.230003.
Recent Progress of Copper-Based Nanomaterials in Tumor-Targeted Photothermal Therapy/Photodynamic Therapy.
Zhuo X, Liu Z, Aishajiang R, Wang T, Yu D
Pharmaceutics. 2023; 15(9).
PMID: 37765262
PMC: 10534922.
DOI: 10.3390/pharmaceutics15092293.
Hen egg white lysozyme encapsulated in ZIF-8 for performing promiscuous enzymatic Mannich reaction.
Kalhor H, Piraman Z, Fathali Y
iScience. 2023; 26(10):107807.
PMID: 37744039
PMC: 10514465.
DOI: 10.1016/j.isci.2023.107807.
Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review.
Akbari Oryani M, Nosrati S, Javid H, Mehri A, Hashemzadeh A, Karimi-Shahri M
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1377-1404.
PMID: 37715816
DOI: 10.1007/s00210-023-02707-y.
Enhanced Osteogenic Activity and Bone Repair Ability of PLGA/MBG Scaffolds Doped with ZIF-8 Nanoparticles Loaded with BMP-2.
Ma R, Su Y, Cao R, Wang K, Yang P
Int J Nanomedicine. 2023; 18:5055-5072.
PMID: 37701821
PMC: 10493152.
DOI: 10.2147/IJN.S423985.
ZIF-8 induced hydroxyapatite-like crystals enabled superior osteogenic ability of MEW printing PCL scaffolds.
Wang B, Zeng Y, Liu S, Zhou M, Fang H, Wang Z
J Nanobiotechnology. 2023; 21(1):264.
PMID: 37563652
PMC: 10413775.
DOI: 10.1186/s12951-023-02007-w.
Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy.
Han X, Zhou C, Luo X, Pang H, Han C, Tang L
Curr Mol Med. 2023; 24(5):648-666.
PMID: 37312441
DOI: 10.2174/1566524023666230613140341.
Nanoparticles of Cerium-Doped Zeolitic Imidazolate Framework-8 Promote Soft Tissue Integration by Reprogramming the Metabolic Pathways of Macrophages.
Yan Q, Shi S, Ge Y, Wan S, Li M, Li M
ACS Biomater Sci Eng. 2023; 9(7):4241-4254.
PMID: 37290028
PMC: 10337665.
DOI: 10.1021/acsbiomaterials.3c00508.
Tannic acid may ameliorate doxorubicin-induced changes in oxidative stress parameters in rat spleen.
Kizir D, Karaman M, Ceylan H
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3605-3613.
PMID: 37272930
DOI: 10.1007/s00210-023-02563-w.
A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8.
Poddar A, Pyreddy S, Polash S, Doherty C, Shukla R
Biomater Biosyst. 2023; 8:100065.
PMID: 36824375
PMC: 9934432.
DOI: 10.1016/j.bbiosy.2022.100065.
Antioxidant Cascade Nanoenzyme Antagonize Inflammatory Pain by Modulating MAPK/p-65 Signaling Pathway.
Ling Y, Nie D, Huang Y, Deng M, Liu Q, Shi J
Adv Sci (Weinh). 2023; 10(12):e2206934.
PMID: 36808856
PMC: 10131840.
DOI: 10.1002/advs.202206934.
Multifunctional inorganic biomaterials: New weapons targeting osteosarcoma.
Wang D, Peng Y, Li Y, Kpegah J, Chen S
Front Mol Biosci. 2023; 9:1105540.
PMID: 36660426
PMC: 9846365.
DOI: 10.3389/fmolb.2022.1105540.
Metal-Organic Frameworks as Intelligent Drug Nanocarriers for Cancer Therapy.
Cai X, Bao X, Wu Y
Pharmaceutics. 2022; 14(12).
PMID: 36559134
PMC: 9781098.
DOI: 10.3390/pharmaceutics14122641.
Recent advances in responsive hydrogels for diabetic wound healing.
Zhang S, Ge G, Qin Y, Li W, Dong J, Mei J
Mater Today Bio. 2022; 18:100508.
PMID: 36504542
PMC: 9729074.
DOI: 10.1016/j.mtbio.2022.100508.
Co-Delivery of Dihydroartemisinin and Indocyanine Green by Metal-Organic Framework-Based Vehicles for Combination Treatment of Hepatic Carcinoma.
Chen Y, Wang B, Chen W, Wang T, Li M, Shen Z
Pharmaceutics. 2022; 14(10).
PMID: 36297482
PMC: 9610498.
DOI: 10.3390/pharmaceutics14102047.